Bok Financial Private Wealth, Inc. Neurocrine Biosciences Inc Put Options Transaction History
Bok Financial Private Wealth, Inc.
- $1.37 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.21 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$583 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$359 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$302 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...